Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Neuropathy (CIPN) and Paclitaxel-induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Study
Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Neuropathy (CIPN) and Paclitaxel-induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Study